Most people suffer from some type of back pain during their lifetime. That’s because there are many joints in the back that can degenerate over time. In many cases, back pain can be relieved without surgery. Ice packs, heat packs, physical therapy or injections can offer relief. However, for those who suffer from degenerative disk disease, in which the tissue in a disk in the lower back breaks down, there are few treatment options. These patients may suffer chronic, debilitating pain that can impact quality of life.
According to Mohamad Bydon, M.D., the genetic signatures which underpin the disease remain unclassified, especially for young patients who develop the condition. That’s why Mayo Clinic Center for Individualized Medicine is supporting research to identify molecular changes associated with the condition, with the hopes of finding new individualized therapies.
“Young patients can develop degenerative disk disease. As a multidisciplinary team, we are examining whether certain genetic events predispose patients to this condition,” says Dr. Bydon, a Mayo Clinic neurosurgeon and a member of the research team exploring individualized therapies for degenerative disk disease.
Genomic testing could help find answers, new treatments
During surgery to repair disk damage, Dr. Bydon and his colleagues are obtaining samples of disk tissue for genomic testing to help answer these questions:
According to Dr. Bydon, this research could be especially important for patients for whom corrective surgery doesn’t work or isn’t a good choice.
“Many older patients have other complex health conditions, making them poor candidates for surgical treatment. Targeted therapies would offer these older patients a new, safer option for treatment and could help reduce their pain and improve their quality of life,” says Dr. Bydon.
Teamwork key to advancing care
"Support from the Center for Individualized Medicine has allowed us to bring together clinicians and researchers from across Mayo Clinic to help patients with degenerative disk disease find relief from their painful symptoms and return to their daily activities. This collaboration to solve unmet patient needs is what sets Mayo apart." – Mohamad Bydon, M.D.
Dr. Bydon is collaborating with a multidisciplinary team that includes neurosurgeons, orthopedic surgeons, physiatrists (experts in the diagnosis, prevention and treatment of disabilities of all types), biomedical engineers, geneticists, genetic counselors and bioinformatics experts.
“Support from the Center for Individualized Medicine has allowed us to bring together clinicians and researchers from across Mayo Clinic to help patients with degenerative disk disease find relief from their painful symptoms and return to their daily activities. This collaboration to solve unmet patient needs is what sets Mayo apart – we are able to pool expertise to help improve the lives of our patients. We hope this research will lead to new treatment options for patients,” says Dr. Bydon
Join the conversation
See highlights from our recent Individualizing Medicine Conference 2017: Advancing Care Through Genomics:
Save the date for next year’s Individualizing Medicine Conference. It will be held Sept. 12-13, 2018.
Tags: #CIMCon17, #degenerative disk disease, #DNA sequencing tests, #Dr. A. Noelle Larson, #Dr. Ahmad Nassr, #Dr. Andre van Wijnen, #Dr. Mohamad Bydon, #Dr. Wenchun Qu, #genomic profling, #genomic testing, #minimally invasive spine surgery, #targeted therapies, center for individualized medicine, mayo clinic, medical research, Precision Medicine